Transcatheter implantation of aortic valve prostheses into degenerated mitral valve bioprostheses and failed annuloplasty rings: outcomes according to access route and Mitral Valve Academic Research Consortium (MVARC) criteria

EuroIntervention 2016;12:1520-1526. DOI: 10.4244/EIJ-D-16-00209

Christian Frerker
Christian Frerker1*, MD; Tobias Schmidt1, MD; Michael Schlüter2, PhD; Ralf Bader3, MD; Jury Schewel1, MD; Dimitry Schewel1, MD; Thomas Thielsen1, MD; Felix Kreidel1, MD; Hannes Alessandrini1, MD; Friederike Schlingloff3, MD; Ulrich Schäfer1, MD; Karl-Heinz Kuck1, MD
1. Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany; 2. Asklepios Proresearch, Hamburg, Germany; 3. Department of Cardiac Surgery, Asklepios Klinik St. Georg, Hamburg, Germany

Aims: The study sought to assess outcomes of transcatheter mitral valve-in-valve implantation (TMVIV) for degenerated bioprostheses and transcatheter mitral valve-in-ring implantation (TM

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

mitral valve diseasetavitransapicaltransseptalvalve-in-valve
Interventions for valvular diseaseMitral valve replacement and repairTools, devices and techniques
Read next article
Initial experience with live three-dimensional image overlay for ductal stenting in hypoplastic left heart syndrome

Latest news